Dipeptidyl peptidase 4 concentration influenced by serum insulin levels rather than arterial stiffness index in type 2 diabetics

about

High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-c

P2860

Q47174356-8993DF22-7AA4-4AB0-8297-72CDC12EC2B3

P2860

Dipeptidyl peptidase 4 concentration influenced by serum insulin levels rather than arterial stiffness index in type 2 diabetics

Item

http://www.wikidata.org/entity/Q35791546

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@ast

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@en

type

Item

label

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@ast

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@en

prefLabel

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@ast

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@en

P1476

Dipeptidyl peptidase 4 concent ...... ness index in type 2 diabetics

@en

P2093

Cong Ma

http://www.w3.org/2001/XMLSchema#string

Hongguang Sheng

http://www.w3.org/2001/XMLSchema#string

Liming Wu

http://www.w3.org/2001/XMLSchema#string

Qiaorui Liu

http://www.w3.org/2001/XMLSchema#string

Qing Gong

http://www.w3.org/2001/XMLSchema#string

Risu Na

http://www.w3.org/2001/XMLSchema#string

Xin Ding

http://www.w3.org/2001/XMLSchema#string

Xudong Mao

http://www.w3.org/2001/XMLSchema#string

Xulei Zheng

http://www.w3.org/2001/XMLSchema#string

Zhiwen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes

Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM

Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors.

Rationale, design, and baseline characteristics of a trial for the prevention of diabetic atherosclerosis using a DPP-4 inhibitor: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.

DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes.

P304

6236-6241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26131231

http://www.w3.org/2001/XMLSchema#string

P932

4483849

http://www.w3.org/2001/XMLSchema#string

Dipeptidyl peptidase 4 concentration influenced by serum insulin levels rather than arterial stiffness index in type 2 diabetics

about

P2860

P2860

Dipeptidyl peptidase 4 concentration influenced by serum insulin levels rather than arterial stiffness index in type 2 diabetics

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932